(Q37167573)

English

Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada

scientific article published on January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

Europe PubMed Central

Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

0 references

Deborah Marshall

object named as

Deborah A Marshall

1

0 references

author name string

Patrick R Douglas

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Michael F Drummond

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

George W Torrance

4

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Stuart Macleod

5

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Orlando Manti

6

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Lokanadha Cheruvu

7

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Ron Corvari

8

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

477-495

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawals

1 reference

https://pubmed.ncbi.nlm.nih.gov/18489199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Guidelines for economic evaluation of pharmaceuticals: Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/18489199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal of Polish guidelines for conducting financial analysis and their comparison to existing guidance on budget impact in other countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/18489199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18489199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18489199

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200826060-00003

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37167573&oldid=2199967862"